Synopsys (SNPS) PT Raised to $660 at KeyBanc

KeyBanc analyst Jason Celino raised the price target on Synopsys (NASDAQ: SNPS) to $660.00 (from $610.00) while maintaining an Overweight rating.

The analyst commented: "Synopsys reports its long-awaited F3Q results on September 9, AMC. Notably, this marks the first quarter that the Company will report its combined financials and guidance, inclusive of the recently closed ANSS deal. We're expecting ANSS to contribute $100M+ in F3Q, and $750M+ in FY25, and for modest upside on "ex-ANSS" F3Q and FY25 figures. We also provide an early look at potential FY26 combined numbers, and raise our PT to $660 to reflect our optimism in the Company's ability to execute as a unified entity. Reiterate OW."

You May Also Be Interested In